It has also been observed to decrease the proliferation and survival of cell lines derived from hematological neoplasms by decreasing the expression of crucial transcription factors such as NK-κB, STAT1, or MYC (90, 91). This evidence concerns the gene STAT1 and hematopoietic and lymphoid system neoplasm.